Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass

被引:10
|
作者
Wang, Xiaocou [1 ,2 ,3 ]
Xue, Qinghua [2 ,3 ]
Yan, Fuxia [2 ,3 ]
Liu, Jinping [3 ,4 ]
Li, Shoujun [3 ,5 ]
Hu, Shengshou [3 ,5 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol Crit Care & Pain Med, Wenzhou, Zhejiang, Peoples R China
[2] Chinese Acad Med Sci, Dept Anesthesiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Chinese Acad Med Sci, Dept Cardiopulm Bypass, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China
[5] Chinese Acad Med Sci, Dept Surg, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 12期
关键词
N-ACETYLCYSTEINE; RENAL INJURY; INFLAMMATION; INHIBITOR; DURATION;
D O I
10.1371/journal.pone.0144516
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective Infants are more vulnerable to kidney injuries induced by inflammatory response syndrome and ischemia-reperfusion injury following cardiopulmonary bypass especially with prolonged hypothermic low-flow (HLF). This study aims to evaluate the protective role of ulinastatin, an anti-inflammatory agent, against acute kidney injuries in infant piglets model undergoing surgery on HLF cardiopulmonary bypass. Methods Eighteen general-type infant piglets were randomly separated into the ulinastatin group (Group U, n = 6), the control group (Group C, n = 6), and the sham operation group (Group S, n = 6), and anaesthetized. The groups U and C received following experimental procedure: median thoracotomy, routine CPB and HLF, and finally weaned from CPB. The group S only underwent sham median thoracotomy. Ulinastatin at a dose of 5,000 units/kg body weight and a certain volume of saline were administrated to animals of the groups U and C at the beginning of CPB and at aortic declamping, respectively. Venous blood samples were collected at 3 different time points: after anesthesia induction in all experimental groups, 5 minutes, and 120 minutes after CPB in the Groups U and C. Markers for inflammation and acute kidney injury were tested in the collected plasma. N-acetyl-beta-D-glucosaminidase (NAG) from urine, markers of oxidative stress injury and TUNEL-positive cells in kidney tissues were also detected. Results The expressions of plasma inflammatory markers and acute kidney injury markers increased both in Group U and Group C at 5 min and 120 min after CPB. Also, numbers of TUNEL-positive cells and oxidative stress markers in kidney rose in both groups. At the time point of 120-min after CPB, compared with the Group C, some plasma inflammatory and acute kidney injury markers as well as TUNEL-positive cells and oxidative stress markers in kidney were significantly reduced in the Group U. Histologic analyses showed that HLF promoted acute tubular necrosis and dilatation. Conclusions HLF cardiopulmonary bypass surgery could intensify systemic inflammatory responses and oxidative stress on infant piglets, thus causing acute kidney injury. Ulinastatin might reduce such inflammatory response and oxidative stress and the extent of kidney injury.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Experimental determination of the safe minimum perfusion flow rate for low-flow hypothermic cardiopulmonary bypass
    Nara, M
    Chiba, Y
    Niwa, H
    Kimura, T
    Ihaya, A
    Morioka, K
    Uesaka, T
    Tsuda, T
    Muraoka, R
    CARDIOVASCULAR SURGERY, 1999, 7 (07): : 715 - 722
  • [22] Acute Kidney Injury and Cardiopulmonary Bypass Surgery Reply
    Sickeler, Robert
    Stafford-Smith, Mark
    ANNALS OF THORACIC SURGERY, 2014, 98 (02): : 784 - 784
  • [23] The limits of detectable cerebral perfusion by transcranial Doppler sonography in neonates undergoing deep hypothermic low-flow cardiopulmonary bypass
    Zimmerman, AA
    Burrows, FA
    Jonas, RA
    Hickey, PR
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (04): : 594 - 600
  • [24] HYPOTHERMIC LOW-FLOW CARDIOPULMONARY BYPASS TECHNIQUE FOR THE REPAIR OF CONGENITAL HEART-DISEASE
    IMAMURA, H
    TAKEUCHI, S
    KATOGI, T
    MAEHARA, T
    INOUE, T
    JOURNAL OF THE JAPANESE ASSOCIATION FOR THORACIC SURGERY, 1980, 28 (12): : 1796 - 1802
  • [25] Serum Metabolic Fingerprint of Acute Kidney Injury Following Infant Cardiac Surgery With Cardiopulmonary Bypass
    Davidson, Jesse
    Frank, Benjamin
    Urban, Tracy
    Khailova, Ludmila
    Klawitter, Jelena
    CIRCULATION, 2019, 140
  • [26] Ulinastatin to prevent acute kidney injury after cardiopulmonary bypass surgery: does serum creatinine tell the whole story?
    Honore, Patrick M.
    Spapen, Herbert D.
    CRITICAL CARE, 2016, 20
  • [27] Ulinastatin to prevent acute kidney injury after cardiopulmonary bypass surgery: does serum creatinine tell the whole story?
    Patrick M. Honore
    Herbert D. Spapen
    Critical Care, 20
  • [28] DEVELOPMENTAL AND NEUROLOGIC STATUS OF CHILDREN AFTER HEART-SURGERY WITH HYPOTHERMIC CIRCULATORY ARREST OR LOW-FLOW CARDIOPULMONARY BYPASS
    BELLINGER, DC
    JONAS, RA
    RAPPAPORT, LA
    WYPIJ, D
    WERNOVSKY, G
    KUBAN, KCK
    BARNES, PD
    HOLMES, GL
    HICKEY, PR
    STRAND, RD
    WALSH, AZ
    HELMERS, SL
    CONSTANTINOU, JE
    CARRAZANA, EJ
    MAYER, JE
    HANLEY, FL
    CASTANEDA, AR
    WARE, JH
    NEWBURGER, JW
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (09): : 549 - 555
  • [29] Effects of pulmonary artery perfusion with urinary trypsin inhibitor as a lung protective strategy under hypothermic low-flow cardiopulmonary bypass in an infant piglet model
    Li, W.
    Wu, X.
    Yan, F.
    Liu, J.
    Tang, Y.
    Ma, K.
    Li, S.
    PERFUSION-UK, 2014, 29 (05): : 434 - 442
  • [30] WHOLE-BODY OXYGEN-CONSUMPTION DURING LOW-FLOW HYPOTHERMIC CARDIOPULMONARY BYPASS
    HICKEY, RF
    HOAR, PF
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 86 (06): : 903 - 906